Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Fractyl Health (GUTS) Gains from Sales and Divestitures (2024)

Historic Gains from Sales and Divestitures for Fractyl Health (GUTS) over the last 1 years, with Q4 2024 value amounting to $604509.0.

  • Fractyl Health's Gains from Sales and Divestitures changed N/A to $604509.0 in Q4 2024 from the same period last year, while for Dec 2024 it was $604509.0, marking a year-over-year change of. This contributed to the annual value of $604509.0 for FY2024, which is N/A changed from last year.
  • As of Q4 2024, Fractyl Health's Gains from Sales and Divestitures stood at $604509.0.
  • Fractyl Health's 5-year Gains from Sales and Divestitures high stood at $604509.0 for Q4 2024, and its period low was $604509.0 during Q4 2024.